Cowen Starts Ocular Therapeutix (OCUL) at Outperform

Cowen initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with an Outperform rating and a price target of $40.00.

For an analyst ratings summary and ratings history on Ocular Therapeutix click here. For more ratings news on Ocular Therapeutix click here.

Shares of Ocular Therapeutix closed at $14.33 yesterday.

You May Also Be Interested In

• Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
• BofA Securities Reinstates Rentokil Initial Plc. (RTO:LN) (RTOKY) at Buy
• Nomura/Instinet Starts Westports Holdings Bhd (WPRTS:MK) at Buy